Treede RD, Meyer RA, Raja SN, Campbell JN: Peripheral and central mechanisms of cutaneous hyperalgesia. Prog Neurobiol 1992, 38:397–421.
Fock S, Mense S: Excitatory effects of 5-hydroxytryptamine, histamine and potassium ions on muscular group IV afferent units: a comparison with bradykinin. Brain Res 1976, 105:459–469.
Griesbacher T, Lembeck F: Effect of bradykinin antagonists on bradykinin-induced plasma extravasation, venoconstriction, prostaglandin E2 release, nociceptor stimulation and contraction of the iris sphincter muscle in the rabbit. Br J Pharmacol 1987, 92:333–340.
Mense S: Nociception from skeletal muscle in relation to clinical muscle pain. Pain 1993, 54:241–289.
Mense S: Nociceptors in skeletal muscle and their reaction to pathological tissue changes. In Neurobiology of Nociceptors.Edited by Belmonte C, Cervero F. Oxford: Oxford Univ. Press;1996:184–201.
Schaible HG, Grubb BD: Afferent and spinal mechanisms of joint pain. Pain 1993, 55:5–54.
Barber LA, Vasko MR: Activation of protein kinase C augments peptide release from rat sensory neurons. J Neurochem 1996, 67:72–80.
Khasar SG, Ouseph AK, Chou B, et al.: Is there more than one prostaglandin E receptor subtype mediating hyperalgesia in the rat hindpaw? Neuroscience 1995, 64:1161–1165.
Abbott FV, Hong Y, Blier P: Persisting sensitization of the behavioral response to formalin-induced injury in the rat through activation of serotonin2A receptors. Neuroscience 1997, 77:575–584.
Sann H, Pierau FK: Efferent functions of C-fiber nociceptors. Z Rheumatol 1998, 57(Suppl 2):8–13.
Kitchener PD, Wilson P, Snow PJ: Selective labeling of primary sensory afferent terminals in lamina II of the dorsal horn by injection of Bandeiraea simplicifolia isolectin B4 into peripheral nerves. Neuroscience 1993, 54:545–551.
Stucky CL, Gold MS, Zhang X: Mechanisms of pain. Proc Natl Acad Sci U S A 2001, 98:11845–11846.
Caterina MJ, Julius D: The vanilloid receptor: a molecular gateway to the pain pathway. Annu Rev Neurosci 2001, 24:487–517.The vanilloid receptor is essential for selective modalities of pain sensation and thermal hyperalgesia
Gunthorpe MJ, Smith GD, Davis JB, Randall AD: Characterization of a human acid-sensing ion channel (hASIC1a) endogenously expressed in HEK293 cells. Pflugers Arch 2001, 442:668–674.
Burnstock G: P2 purinoceptors: historical perspective and classification. Ciba Found Symp 1996, 198:1–28.
Caterina MJ, Leffler A, Malmberg AB, Martin WJ, et al.: Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science 2000, 288:306–313.
Lewis T: Experiments relating to cutaneous hyperalgesia and its spread through somatic fibres. Clin Sci (Colch) 1935, 2:373–423.
Hardy JD, Wolff HG, Goodell H: Experimental evidence on the nature of cutaneous hyperalgesia. J Clin Invest 1950, 29:115–140.
Koltzenburg M: Neural mechanisms of cutaneous nociceptive pain. Clin J Pain 2000, 16:S131-S138.Primary hyperalgesia is related to changes in primary nociceptive afferents, whereas secondary hyperalgesia (increased pain sensitivity outside the area of tissue injury) critically requires functional changes in the central nervous system.
Simms RW, Roy SH, Hrovat M, Anderson JJ, et al.: Lack of association between fibromyalgia syndrome and abnormalities in muscle energy metabolism. Arthritis Rheum 1994, 37:794–800.
De Stefano R, Selvi E, Villanova M, Frati E, et al.: Image analysis quantification of substance P immunoreactivity in the trapezius muscle of patients with fibromyalgia and myofascial pain syndrome. J Rheumatol 2000, 27:2906–2910.
Li J, Simone DA, Larson AA: Windup leads to characteristics of central sensitization. Pain 1999, 79:75–82.
Wall PD, Woolf CJ: Muscle but not cutaneous C-afferent input produces prolonged increases in the excitability of the flexion reflex in the rat. J Physiol Lond 1984, 356:443–458.
Schaible HG, Schmidt RF: Neurobiology of articular nociceptors. In Neurobiology of Nociceptors. Edited by Belmonte C, Cervero F. Oxford: Oxford Univ Press; 1996:202–219.
Coggeshall RE, Carlton SM: Receptor localization in the mammalian dorsal horn and primary afferent neurons. Brain Res Brain Res Rev 1997, 24:28–66.
Malcangio M, Bowery NG: GABA and its receptors in the spinal cord. Trends Pharmacol Sci 1996, 17:457–462.
Schadrack J, Zieglgansberger W: Pharmacology of pain processing systems. Z Rheumatol 1998, 57 Suppl 2:1–4.
Fields HL, Basbaum AI: Central nervous system mechanisms of pain modulation. In Textbook of Pain. Edited by Wall PD,Melzack R. Edinburgh: Churchill-Livingstone; 1994:243–257.
Mao JR: NMDA and opioid receptors: their interactions in antinociception, tolerance and neuroplasticity. Brain Res Rev 1999, 30:289–304.
Gracy KN, Svingos AL, Pickel VM: Dual ultrastructural localization of mu-opioid receptors and NMDA-type glutamate receptors in the shell of the rat nucleus accumbens. J Neurosci 1997, 17:4839–4848.
Davidson EM, Coggeshall RE, Carlton SM: Peripheral NMDA and non-NMDA glutamate receptors contribute to nociceptive behaviors in the rat formalin test. Neuroreport 1997, 8:941–946.
Coggeshall RE, Zhou S, Carlton SM: Opioid receptors on peripheral sensory axons. Brain Res 1997, 764:126–132.
Kolesnikov Y, Pasternak GW: Topical opioids in mice: analgesia and reversal of tolerance by a topical N-methyl-Daspartate antagonist. J Pharmacol Exp Ther 1999, 290:247–252.
Stein C, Machelska H, Binder W, Schafer M: Peripheral opioid analgesia. Curr Opin Pharmacol 2001, 1:62–65.
Hassan AH, Ableitner A, Stein C, Herz A: Inflammation of the rat paw enhances axonal transport of opioid receptors in the sciatic nerve and increases their density in the inflamed tissue. Neuroscience 1993, 55:185–195.
Chapman V, Haley JE, Dickenson AH: Electrophysiologic analysis of preemptive effects of spinal opioids on N-methyl-D-aspartate receptor-mediated events. Anesthesiology 1994, 81:1429–1435.
Sivilotti LG, Gerber G, Rawat B, Woolf CJ: Morphine selectively depresses the slowest, NMDA-independent component of C-fibre-evoked synaptic activity in the rat spinal cord in vitro. Eur J Neurosci 1995, 7:12–18.
Vaughan CW, Christie MJ: Presynaptic inhibitory action of opioids on synaptic transmission in the rat periaqueductal grey in vitro. J Physiol 1997, 498(Pt2):463–472.
Zhang KM, Wang XM, Mokha SS: Opioids modulate N-methyl-D-aspartic acid (NMDA)-evoked responses of neurons in the superficial and deeper dorsal horn of the medulla (trigeminal nucleus caudalis). Brain Res 1996, 719:229–233.
Basbaum AI: Spinal mechanisms of acute and persistent pain. Reg Anesth Pain Med 1999, 24:59–67.Persistent pain should be considered a disease of the nervous system, not a symptom of a specific disease. In the setting of persistent injury, the nervous system undergoes extensive changes that exacerbate and prolong the pain condition.
Mao J, Price DD, Mayer DJ: Mechanisms of hyperalgesia and morphine tolerance: a current view of their possible interactions. Pain 1995, 62:259–274.
Coyle JT, Puttfarcken P: Oxidative stress, glutamate, and neurodegenerative disorders. Science 1993, 262:689–695.
Bliss TV, Collingridge GL: A synaptic model of memory: long-term potentiation in the hippocampus. Nature 1993, 361:31–39.
Bredt DS, Snyder SH: Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc Natl Acad Sci U S A 1989, 86:9030–9033.
Brenman JE, Bredt DS: Synaptic signaling by nitric oxide. Curr Opin Neurobiol 1997, 7:374–378.
Schuman EM, Madison DV: Nitric oxide and synaptic function. Annu Rev Neurosci 1994, 17:153–183.
Wang X, Robinson PJ: Cyclic GMP-dependent protein kinase and cellular signaling in the nervous system. J Neurochem 1997, 68:443–456.
Meller ST, Gebhart GF: Nitric oxide (NO) and nociceptive processing in the spinal cord. Pain 1993, 52:127–136.
McMahon SB, Lewin GR, Wall PD: Central hyperexcitability triggered by noxious inputs. Curr Opin Neurobiol 1993, 3:602–610.
Radhakrishnan V, Yashpal K, Hui-Chan CW, Henry JL: Implication of a nitric oxide synthase mechanism in the action of substance P: L-NAME blocks thermal hyperalgesia induced by endogenous and exogenous substance P in the rat. Eur J Neurosci 1995, 7:1920–1925.
Aimar P, Pasti L, Carmignoto G, Merighi A: Nitric oxideproducing islet cells modulate the release of sensory neuropeptides in the rat substantia gelatinosa. J Neurosci 1998, 18:10375–10388.
Urban L, Thompson SW, Dray A: Modulation of spinal excitability: co-operation between neurokinin and excitatory amino acid neurotransmitters. Trends Neurosci 1994, 17:432–438.
Mendell LM, Wall PD: Responses of single dorsal cord cells to peripheral cutaneous unmyelinated fibres. Nature 1965, 206:97–99.
Davies SN, Lodge D: Evidence for involvement of N-methylaspartate receptors in ‘wind-up’ of class 2 neurones in the dorsal horn of the rat. Brain Res 1987, 424:402–406.
Dickenson AH, Sullivan AF: Evidence for a role of the NMDA receptor in the frequency dependent potentiation of deep rat dorsal horn nociceptive neurones following C fibre stimulation. Neuropharmacology 1987, 26:1235–1238.
Dickenson AH: A cure for wind up: NMDA receptor antagonists as potential analgesics. Trends Pharmacol Sci 1990, 11:307–309.
Price DD: Characteristics of second pain and flexion reflexes indicative of prolonged central summation. Exp Neurol 1972, 37:371–387.
Price DD, Hu JW, Dubner R, Gracely RH: Peripheral suppression of first pain and central summation of second pain evoked by noxious heat pulses. Pain 1977, 3:57–68.
Woolf CJ, Costigan M: Transcriptional and posttranslational plasticity and the generation of inflammatory pain. Proc Natl Acad Sci U S A 1999, 96:7723–7730.Pain hypersensitivity is related to early post-translational changes in the peripheral terminals of the nociceptor and in dorsal horn neurons, followed by transcription-dependent changes in effector genes (in primary sensory and dorsal horn neurons). This neuroplasticity is the result of membrane protein changes, activation of transcription factors, and altering of gene expression. Potentiation of nociceptive signals occurs as a result of the up-regulation in the dorsal root ganglion of centrally acting neuromodulators and simultaneously in the dorsal horn of the spinal cord. A-fibers can acquire the neurochemical features typical of C-fibers, enabling these fibers to induce stimulus-evoked hypersensitivity, something only C-fiber inputs normally can do.
Staud R, Vierck CJ, Cannon RL, et al.: Abnormal sensitization and temporal summation of second pain (wind-up) in patients with fibromyalgia syndrome. Pain 2001, 91:165–175.Temporal summation of second pain is a C-fiber-mediated event and is relevant to pain processing. Compared with normal controls, FMS subjects were hyperalgesic and demonstrated a greater amount of temporal summation. In addition, after-sensations were greater in magnitude, lasted longer, and were frequently more painful in FMS subjects.
Vierck CJ, Staud R, Price DD, et al.: The effect of exercise on temporal summation of second pain (wind-up) in patients with fibromyalgia syndrome. J Pain 2001, 2:334–345.Patients with FMS showed greater wind-up during heat stimuli than normal controls. Maximal exercise attenuated windup in normal control groups, but augmented it in patients with FMS. This finding suggests abnormal pain modulation in FMS.
Price DD, Staud R, Robinson ME, et al.: Enhanced temporal summation of second pain and its central modulation in fibromyalgia patients. Pain 2002, in press.
Liu H, Brown JL, Jasmin L, et al.: Synaptic relationship between substance P and the substance P receptor: light and electron microscopic characterization of the mismatch between neuropeptides and their receptors. Proc Natl Acad Sci U S A 1994, 91:1009–1013.
Liu H, Wang H, Sheng M, et al.: Evidence for presynaptic N-methyl-D-aspartate autoreceptors in the spinal cord dorsal horn. Proc Natl Acad Sci U S A 1994, 91:8383–8387.
Liu H, Mantyh PW, Basbaum AI: NMDA-receptor regulation of substance P release from primary afferent nociceptors. Nature 1997, 386:721–724.
Curran T, Morgan JI: Fos: an immediate-early transcription factor in neurons. J Neurobiol 1995, 26:403–412.
Coderre TJ, Katz J, Vaccarino AL, Melzack R: Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence. Pain 1993, 52:259–285.
Tsigos C, Diemel LT, White A, et al.: Cerebrospinal fluid levels of substance P and calcitonin-gene-related peptide: correlation with sural nerve levels and neuropathic signs in sensory diabetic polyneuropathy. Clin Sci Colch 1993, 84:305–311.
Vaeroy H, Helle R, Forre O, et al.: Elevated CSF levels of substance P and high incidence of Raynaud phenomenon in patients with fibromyalgia: new features for diagnosis. Pain 1988, 32:21–26.
Russell IJ, Orr MD, Littman B, et al.: Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome. Arthritis Rheum 1994, 37:1593–1601.
Watkins LR, Wiertelak EP, Furness LE, Maier SF: Illness-induced hyperalgesia is mediated by spinal neuropeptides and excitatory amino acids. Brain Res 1994, 664:17–24.
Mannion RJ, Costigan M, Decosterd I, et al.: Neurotrophins: peripherally and centrally acting modulators of tactile stimulus-induced inflammatory pain hypersensitivity. Proc Natl Acad Sci U S A 1999, 96:9385–9390.
Dyck PJ, Peroutka S, Rask C, et al.: Intradermal recombinant human nerve growth factor induces pressure allodynia and lowered heat-pain threshold in humans. Neurology 1997, 48:501–505.
Petty BG, Cornblath DR, Adornato BT, et al.: The effect of systemically administered recombinant human nerve growth factor in healthy human subjects. Ann Neurol 1994, 36:244–246.
Giovengo SL, Russell IJ, Larson AA: Increased concentrations of nerve growth factor in cerebrospinal fluid of patients with fibromyalgia. J Rheumatol 1999, 26:1564–1569.
Woolf CJ, Safieh-Garabedian B, Ma QP, et al.: Nerve growth factor contributes to the generation of inflammatory sensory hypersensitivity. Neuroscience 1994, 62:327–331.
Ruffolo R, Fuerstein GZ, Hunter AJ, et al.: Inflammatory cells and mediators in CNS diseases. Netherlands: Harwood Academic Press; 1999.
Watkins LR, Maier SF: Cytokines and pain: progress in inflammation research. Boston: Birkhauser; 1999.
Kreutzberg GW: Microglia: a sensor for pathological events in the CNS. Trends Neurosci 1996, 19:312–318.
Raivich G, Bluethmann H, Kreutzberg GW: Signaling molecules and neuroglial activation in the injured central nervous system. Keio J Med 1996, 45:239–247.
Wooten MW: Function for NF-kB in neuronal survival: regulation by atypical protein kinase C. J Neurosci Res 1999, 58:607–611.
Woolf CJ, Allchorne A, Safieh-Garabedian B, Poole S: Cytokines, nerve growth factor and inflammatory hyperalgesia: the contribution of tumour necrosis factor alpha. Br J Pharmacol 1997, 121:417–424.
Wood PL: Neuroinflammation: mechanism and management. Totowa: Humana; 2000.
Crinelli R, Antonelli A, Bianchi M, et al.: Selective inhibition of NF-kB activation and TNF-alpha production in macrophages by red blood cell-mediated delivery of dexamethasone. Blood Cells Mol Dis 2000, 26:211–222.
Johansson A, Bennett GJ: Effect of local methylprednisolone on pain in a nerve injury model. A pilot study. Reg Anesth 1997, 22:59–65.
Binder JR, Swanson SJ, Hammeke TA, et al.: Determination of language dominance using functional MRI: a comparison with the Wada test. Neurology 1996, 46:978–984.
Hui KKS, Liu J, Makris N, et al.: Acupuncture modulates the limbic system and subcortical gray structures of the human brain: Evidence from fMRI studies in normal subjects. Hum Brain Mapp 2000, 9:13–25.
Coghill RC, Talbot JD, Evans AC, et al.: Distributed processing of pain and vibration by the human brain. J Neurosci 1994, 14:4095–4108.
Coghill RC, Sang CN, Berman KF, et al.: Global cerebral blood flow decreases during pain. J Cereb Blood Flow Metab 1998, 18:141–147.Positron emission tomography studies have identified several brain regions activated by pain. They include the thalamus, insula, anterior cingulate cortex, and somatosensory cortex. The authors found that capsaicin-evoked pain (intradermal injection) decreased global cerebral blood flow from resting levels.
Coghill RC, Gilron I, Iadarola MJ: Hemispheric lateralization of somatosensory processing. Journal of Neurophysiology 2001, 85:2602–2612.
Xu X, Fukuyama H, Yazawa S, et al.: Functional localization of pain perception in the human brain studied by PET. Neuroreport 1997, 8:555–559.
Jones AK, Brown WD, Friston KJ, et al.: Cortical and subcortical localization of response to pain in man using positron emission tomography. Proc R Soc Lond B Biol Sci 1991, 244:39–44.
Sakiyama Y, Sato A, Senda M, et al.: Positron emission tomography reveals changes in global and regional cerebral blood flow during noxious stimulation of normal and inflamed elbow joints in anesthetized cats. Exp Brain Res 1998, 118:439–446.
Hofbauer RK, Rainville P, Duncan GH, Bushnell MC: Cortical representation of the sensory dimension of pain. Journal of Neurophysiology 2001, 86:402–411.
Mountz JM, Bradley LA, Modell JG, et al.: Fibromyalgia in women. Abnormalities of regional cerebral blood flow in the thalamus and the caudate nucleus are associated with low pain threshold levels. Arthritis Rheum 1995, 38:926–938.
Kwiatek R, Barnden L, Tedman R, et al.: Regional cerebral blood flow in fibromyalgia: single-photon-emission computed tomography evidence of reduction in the pontine tegmentum and thalami. Arthritis Rheum 2000, 43:2823–2833.
Petzke F, Clauw DJ, Wolf JM, Gracely RH: Pressure pain in fibromyalgia and healthy control: Functional MRI of subjective pain experience versus objective stimulus intensity. Arthritis Rheum 2000, 43:S400.